Loading market dashboard
Eupraxia Pharmaceuticals Inc.
EPRX.TOHealthcareTSXCA
Loading analysis workspace
Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Eupraxia Pharmaceuticals Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $152.27M | $152.27M - $152.27M | $0.00 | -$0.50 | 6 |
| Dec 2029 | $48.41M | $48.41M - $48.41M | $0.00 | -$1.58 | 3 |
| Dec 2028 | $9.58M | $9.58M - $9.58M | $0.00 | -$1.572 | 7 |
| Dec 2027 | $15.78M | $15.76M - $15.80M | $0.00 | -$1.181 | 8 |
| Dec 2026 | $15.79M | $15.79M - $15.79M | $0.00 | -$1.167 | 5 |
| Dec 2025 | $45.54M | $45.54M - $45.54M | $0.00 | -$0.864 | 4 |
| Dec 2024 | $0.00 | $0.00 - $0.00 | $0.00 | -$0.923 | 0 |
| Dec 2022 | $41.00M | $41.00M - $41.00M | $0.00 | -$1.18 | 1 |